HAEM5:Plasma cell myeloma / multiple myeloma: Difference between revisions
| [checked revision] | [pending revision] |
Bailey.Glen (talk | contribs) No edit summary |
Zhenya.Tang (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Plasma cell myeloma / multiple myeloma}} | {{DISPLAYTITLE:Plasma cell myeloma / multiple myeloma}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 14: | Line 15: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
*Huan Mo, MD, MS | *Huan Mo, MD, MS<sup>1</sup> | ||
*Zhenya Tang, MD, PhD | *Zhenya Tang, MD, PhD<sup>2</sup> | ||
<sup>1</sup> Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Cohort Analytics Core (CAC), National Human Genome Research Institute (NHGRI), NIH | |||
<sup>2</sup> University of Nebraska Medical Center, College of Medicine, Department of Pathology, Microbiology and Immunology, Omaha, Nebraska | |||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 40: | Line 43: | ||
|} | |} | ||
==Related Terminology== | ==Related Terminology== | ||